{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Artelo Biosciences, Inc."},"Symbol":{"label":"Symbol","value":"ARTL"},"Address":{"label":"Address","value":"888 PROSPECT STREET SUITE 210, SAN DIEGO, California, 92037, United States"},"Phone":{"label":"Phone","value":"+1 760 943-1689"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease."},"CompanyUrl":{"label":"Company Url","value":"http://www.artelobio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Andy Yates","title":"Chief Scientific Officer &amp; Senior Vice President"},{"name":"Gregory D. Gorgas","title":"President, CEO, CFO, Secretary &amp; Treasurer"},{"name":"Randy Schreckhise","title":"Vice President-Finance &amp; Operations"},{"name":"Steven D. Reich","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}